UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 74

Sortiert nach

Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2268764-2268764

2023

Volltextzugriff (PDF)

Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)

The Journal of dermatological treatment, 2022-07, Vol.33 (5), p.2565-2570

2022

Volltextzugriff (PDF)

Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study

The Journal of dermatological treatment, 2021-02, Vol.32 (2), p.164-173

2021

Volltextzugriff (PDF)

Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus

Dermatology and therapy, 2024-04, Vol.14 (4), p.919-932

2024

Volltextzugriff (PDF)

Tralokinumab‐induced psoriasis relapse in a patient with atopic dermatitis

International journal of dermatology, 2024-07

2024

Volltextzugriff (PDF)

Dupilumab: a new frontier for chronic urticaria. A case series and review of the literature

International journal of dermatology, 2024-03, Vol.63 (3), p.399-401

2024

Volltextzugriff (PDF)

Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata

International journal of dermatology, 2024-03, Vol.63 (3), p.374-375

2024

Volltextzugriff (PDF)

Effectiveness of dupilumab in tralokinumab‐resistant patients with atopic dermatitis: A real‐world experience from two referral centres

Journal of the European Academy of Dermatology and Venereology, 2024-06

2024

Volltextzugriff (PDF)

Effectiveness of dupilumab in the treatment of alopecia areata in patients with concurrent atopic dermatitis: a real‐life retrospective study

International journal of dermatology, 2024-06

2024

Volltextzugriff (PDF)

Mycosis fungoides and Sézary syndrome following dupilumab treatment: experience of two Italian tertiary care centres

Clinical and experimental dermatology, 2023-11, Vol.48 (12), p.1376-1378

2023

Volltextzugriff (PDF)

Eczema herpeticum and herpetic keratitis after the loading dose of dupilumab in a worsening atopic dermatitis: causality?

International journal of dermatology, 2023-12, Vol.62 (12), p.1547-1548

2023

Volltextzugriff (PDF)

Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study

Journal of the American Academy of Dermatology, 2024-05, Vol.90 (5), p.1031-1034

2024

Volltextzugriff (PDF)

Efficacy and tolerability of a repairing moisturizing cream containing amino-inositole and urea 10% in adults with chronic eczematous dermatitis of the hands

Italian journal of dermatology and venereology, 2023-02, Vol.158 (1), p.42

2023

Volltextzugriff (PDF)

Patch testing with textile dye mix in Italy: A 2‐year multicenter SIDAPA study

Contact dermatitis, 2021-04, Vol.84 (4), p.265-268

2021

Volltextzugriff (PDF)

Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study

Advances in therapy, 2023-12, Vol.40 (12), p.5366-5382

2023

Volltextzugriff (PDF)

Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study

Journal of the European Academy of Dermatology and Venereology, 2024-01

2024

Volltextzugriff (PDF)

Effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis: a preliminary report of real-world data

Italian journal of dermatology and venereology, 2022-04, Vol.157 (2), p.211

2022

Volltextzugriff (PDF)

AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST

Italian journal of dermatology and venereology, 2023-04, Vol.158 (2), p.81

2023

Volltextzugriff (PDF)

Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment

Dermatology and therapy, 2022-01, Vol.12 (1), p.195-202

2022

Volltextzugriff (PDF)

Chronic spontaneous urticaria in clinical practice: a pilot survey about attitudes and perceptions on assessment, diagnostic work-up and dietary management

Italian journal of dermatology and venereology, 2021-12, Vol.156 (6), p.659

2021

Volltextzugriff (PDF)

Allergological and Toxicological Aspects in a Multiple Chemical Sensitivity Cohort

Oxidative medicine and cellular longevity, 2013-01, Vol.2013, p.356235-12

2013

Volltextzugriff (PDF)

34332 Treatment patterns and prior medication usage before dupilumab treatment initiation in patients with AD: Real-world data from GLOBOSTAD

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB122-AB122

2022

Volltextzugriff (PDF)

633 - Physician-assessed effectiveness and safety in adolescent and adult atopic dermatitis patients treated with dupilumab: real-world insights one year into the GLOBOSTAD multinational prospective observational study

British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)

2024

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(74)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience

Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)

Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study

Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus

Tralokinumab‐induced psoriasis relapse in a patient with atopic dermatitis

Dupilumab: a new frontier for chronic urticaria. A case series and review of the literature

Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata

Effectiveness of dupilumab in tralokinumab‐resistant patients with atopic dermatitis: A real‐world experience from two referral centres

Effectiveness of dupilumab in the treatment of alopecia areata in patients with concurrent atopic dermatitis: a real‐life retrospective study

Mycosis fungoides and Sézary syndrome following dupilumab treatment: experience of two Italian tertiary care centres

Eczema herpeticum and herpetic keratitis after the loading dose of dupilumab in a worsening atopic dermatitis: causality?

Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study

Efficacy and tolerability of a repairing moisturizing cream containing amino-inositole and urea 10% in adults with chronic eczematous dermatitis of the hands

Patch testing with textile dye mix in Italy: A 2‐year multicenter SIDAPA study

Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study

Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History

AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History

Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study

Effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis: a preliminary report of real-world data

AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST

Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment

Chronic spontaneous urticaria in clinical practice: a pilot survey about attitudes and perceptions on assessment, diagnostic work-up and dietary management

Allergological and Toxicological Aspects in a Multiple Chemical Sensitivity Cohort

34332 Treatment patterns and prior medication usage before dupilumab treatment initiation in patients with AD: Real-world data from GLOBOSTAD

633 - Physician-assessed effectiveness and safety in adolescent and adult atopic dermatitis patients treated with dupilumab: real-world insights one year into the GLOBOSTAD multinational prospective observational study

Suchergebnisse filtern